Suggested Topics within your search.
Showing 1 - 15 results of 15 for search '', query time: 0.05s Refine Results
  1. 1
    New Mechanisms in Glucose Control.

    New Mechanisms in Glucose Control. by Barnett, Anthony H.

    2nd ed.
    Published 2013
    Full text (MCPHS users only)
    Electronic eBook
    Save to List
    Saved in:
  2. 2
    Oral delivery of insulin

    Oral delivery of insulin by Sonia, Thundiparambil Azeez, Sharma, Chandra P.

    Published 2014
    Full text (MCPHS users only)
    Electronic eBook
    Save to List
    Saved in:
  3. 3
    Pharmacoeconomic review report. Empagliflozin and Metformin fixed-dose combination (Synjardy).

    Pharmacoeconomic review report. Empagliflozin and Metformin fixed-dose combination (Synjardy).

    Published 2017
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  4. 4
    CADTH Canadian Drug Expert Committee recommendation. Insulin degludec (Tresiba -- Novo Nordisk Canada Inc.) : indication : diabetes mellitus, types I and II.

    CADTH Canadian Drug Expert Committee recommendation. Insulin degludec (Tresiba -- Novo Nordisk Canada Inc.) : indication : diabetes mellitus, types I and II.

    Version 1.0.
    Published 2017
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  5. 5
    Patient group input submissions. Empagliflozin and metformin (Synjardy) for diabetes mellitus (Type 2).

    Patient group input submissions. Empagliflozin and metformin (Synjardy) for diabetes mellitus (Type 2).

    Published 2017
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  6. 6
    CADTH Canadian Drug Expert Committee recommendation. Lixisenatide (Adlyxine -- Sanofi-Aventis Canada inc.) : indication : diabetes mellitus, type 2.

    CADTH Canadian Drug Expert Committee recommendation. Lixisenatide (Adlyxine -- Sanofi-Aventis Canada inc.) : indication : diabetes mellitus, type 2.

    Version 1.0.
    Published 2017
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  7. 7
    Clinical review report. Lixisenatide (Adlyxine) (Sanofi-aventis Canada Inc.)

    Clinical review report. Lixisenatide (Adlyxine) (Sanofi-aventis Canada Inc.)

    Version: 1.0.
    Published 2017
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  8. 8
    Pharmacoeconomic review report. Empagliflozin (Jardiance).

    Pharmacoeconomic review report. Empagliflozin (Jardiance).

    Published 2015
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  9. 9
    Pharmacoeconomic review report. Insulin degludec (Tresiba) (Novo Nordisk Canada Inc.).

    Pharmacoeconomic review report. Insulin degludec (Tresiba) (Novo Nordisk Canada Inc.).

    Version: 1.0.
    Published 2017
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  10. 10
    Empagliflozin (Jardiance).

    Empagliflozin (Jardiance).

    Published 2015
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  11. 11
    Pharmacoeconomic review report. Lixisenatide (Adlyxine) (Sanofi-aventis Canada Inc.).

    Pharmacoeconomic review report. Lixisenatide (Adlyxine) (Sanofi-aventis Canada Inc.).

    Published 2017
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  12. 12
    Guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus.

    Guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus.

    Published 2018
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  13. 13
    New drugs for type 2 diabetes : second-line therapy -- science report.

    New drugs for type 2 diabetes : second-line therapy -- science report.

    Published 2017
    Get full text
    Full text
    Electronic eBook
    Save to List
    Saved in:
  14. 14
    Patient group input submissions. Canagliflozin and metformin hydrochloride (Invokamet) for type 2 diabetes.

    Patient group input submissions. Canagliflozin and metformin hydrochloride (Invokamet) for type 2 diabetes.

    Published 2018
    Full text
    Electronic eBook
    Save to List
    Saved in:
  15. 15
    Pioglitazone for type 2 diabetes mellitus and pre-diabetes : a review of safety

    Pioglitazone for type 2 diabetes mellitus and pre-diabetes : a review of safety by Marchand, Dave K., Subramonian, Anusree, Featherstone, Robin, Spry, Carolyn

    Published 2020
    Full text
    Electronic eBook
    Save to List
    Saved in:

Search Tools: